A Single Dose Pharmacokinetic Study of LY2189265 in Subjects With Varying Degrees of Hepatic Impairment.
Phase of Trial: Phase I
Latest Information Update: 12 Nov 2014
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 19 Sep 2014 Results of this and another trial presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Dec 2011 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 01 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.